Matthew C Kapusta is a director of Decibel Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | QURE uniQure | Ordinary Shares | Grant | Acquire A | No | No | 0 | 150,000 | 0.00 | 590,839 |
1 Mar 24 | QURE uniQure | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 5.59 | 259,500 | 1.45 mm | 259,500 |
26 Feb 24 | QURE uniQure | Ordinary Shares | Sell | Dispose S | No | No | 6.35 | 27,904 | 177.19 k | 440,839 |
25 Sep 23 | DBTX Decibel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,000 | 0.00 | 0 |
25 Sep 23 | DBTX Decibel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.34 | 10,000 | 33.40 k | 0 |
19 Mar 23 | DBTX Decibel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 10,000 |
19 Mar 23 | DBTX Decibel Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 3.34 | 10,000 | 33.40 k | 10,000 |